Germany-based Symrise AG has made a strategic partnership with Hofseth BioCare ASA (HBC) for the human health and pet nutrition markets. The partnership ideally complements Symrise’s current portfolio with clinically proven marine ingredients, according to the announcement.
Symrise AG has signed a strategic partnership with HBC, a Norwegian manufacturer of salmon-based ingredients addressing the human health and pet nutrition markets. With this partnership, Symrise points out it will expand its presence in the health category with clinically proven marine ingredients. Symrise will ideally complement its current portfolio and accelerate HBC’s market reach and scale.
HBC is committed to ambitious growth plans and envisions to refurbish the HBC Berkak facility into a state-of-the-art enzymatic hydrolysis plant that will triple the current production of HBC, according to the announcement. Symrise and HBC will further explore new product developments and leverage Symrise’s go-to-market to promote HBC products globally.
“This partnership with HBC is testament to their unique footprint and differentiated science. Their investments in clinical studies demonstrate proven benefits in key categories of metabolic health, immune health, gut health and mobility, setting them apart. This partnership is well aligned with our willingness to accelerate in health in the context of our ‘One Care’ journey but also with the recent creation of the Global Marine Platform to explore the vast potential that the oceans could offer us,” said Dr. Jean-Yves Parisot, CEO of Symrise AG.
Sustainability is deeply embedded into HBC’s DNA, the company points out. HBC has developed a unique proprietary technology to upcycle fresh salmon offcuts not used in the production of fillets into bioactive ingredients with demonstrated health benefits. The collaboration between HBC and Symrise is expected to enhance the public awareness of the health value of marine ingredients and further help position HBC as the leader in science-led marine nutrition, globally.
Jon Olav Odegard, CEO of HBC commented: “Symrise have been a key partner for us already and we are very excited to move ahead as they will help transform our scale and market access with their well-established market presence. The human health and premium pet markets continue to grow very strongly, and this partnership will allow us to sustain our growth trajectory and position us as the leading player in the science-led marine nutrition segment dedicated to human health.”
